Role of Genomic Imprinting in Cancer Diagnosis

Clinical trial NCT03882684 · UNKNOWN

Trial details

NCT number: NCT03882684
Sponsor: Chinese Alliance Against Lung Cancer
Status: UNKNOWN
Study type: OBSERVATIONAL

Early Diagnosis Cancer Biomarker Genomic Imprinting

Start date: 2017-07-01
Primary completion: 2019-03-31
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.